Sommaire

• • ·Table of Contents

    Page :i

    
• • ·Editorial Board

    Page :iii

    
• • ·Information for Readers

    Page :v

    

• Editorials

  • ·Blood pressure control in patients with ischemic cardiomyopathy

    Page :186-189

    Johann Auer, Gudrun Lamm

    Plan Plan  

• Trial Designs

  • ·Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists

    Page :38-48

    Amrita Mukhopadhyay, Harmony R. Reynolds, Yuhe Xia, Lawrence M. Phillips, Rod Aminian, Ruth-Ann Diah, Arielle R. Nagler, Adam Szerencsy, Archana Saxena, Leora I. Horwitz, Stuart D. Katz, Saul Blecker

    Résumé Résumé Plan Plan   
  • ·Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial

    Page :77-84

    Christian Spaulding, Florian Krackhardt, Kris Bogaerts, Philip Urban, Susanne Meis, Marie-Claude Morice, Simon Eccleshall

    Résumé Résumé Plan Plan   
  • ·Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial

    Page :119-128

    Sem A.O.F. Rikken, Abi Selvarajah, Renicus S. Hermanides, Barry S. Coller, C. Michael Gibson, Christopher B. Granger, Frédéric Lapostolle, Sonja Postma, Henri van de Wetering, Risco C.W. van Vliet, Gilles Montalescot, Jurriën M. ten Berg, Arnoud W.J. van ’t Hof, CELEBRATE investigators

    Résumé Résumé Plan Plan  
  • ·βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial

    Page :168-176

    Johanne Silvain, Guillaume Cayla, Emile Ferrari, Grégoire Range, Etienne Puymirat, Nicolas Delarche, Jean-Philippe Collet, Raphaelle Dumaine, Michel Slama, Laurent Payot, Mohamad E. Kasty, Karim Aacha, Eric Vicaut, Gilles Montalescot, ABYSS investigators of the ACTION Study Group,

    Résumé Résumé Plan Plan   

• Review Articles

  • ·Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    Page :1-16

    Raquel López-Galvez, José Miguel Rivera-Caravaca, Vanessa Roldán, Esteban Orenes-Piñero, María Asunción Esteve-Pastor, Cecilia López-García, Daniel Saura, Josefa González, Gregory Y.H. Lip, Francisco Marín

    Résumé Résumé Plan Plan  
  • ·Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension

    Page :96-113

    Giuditta Benincasa, Claudio Napoli, Joseph Loscalzo, Bradley A. Maron

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction

    Page :17-26

    Ronak Delewi, Rosanne F. Vogel, Jeroen M. Wilschut, Miguel E. Lemmert, Roberto Diletti, Ria van Vliet, Nancy W.P.L. van der Waarden, Rutger-Jan Nuis, Valeria Paradies, Dimitrios Alexopoulos, Felix Zijlstra, Gilles Montalescot, Dominick J. Angiolillo, Mitchell W. Krucoff, Pieter A. Doevendans, Nicolas M. Van Mieghem, Pieter C. Smits, Georgios J. Vlachojannis

    Résumé Résumé Plan Plan   
  • ·Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data

    Page :27-37

    Robert J. Cubeddu, Shannon M.E. Murphy, Craig R. Asher, Santiago A. Garcia, Juan F. Granada, Creighton W. Don, Sankalp Patel, Mazen S. Albaghdadi, João L. Cavalcante, Megan Coylewright, Rebecca T. Hahn, Philippe Genereux, Pradeep K. Yadav, Vinod H. Thourani, Martin B. Leon

    Résumé Résumé Plan Plan   
  • ·Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor

    Page :49-59

    Matthew Johnson, Fritha J. Morrison, Gearoid McMahon, Maxwell Su, Alexander Turchin

    Résumé Résumé Plan Plan  
  • ·Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial

    Page :60-68

    Kelley R.H. Branch, Jeffrey L. Probstfield, Jackie Bosch, Deepak L. Bhatt, Aldo P. Maggioni, Eva Muehlhofer, Alvaro Avezum, Petr Widimsky, Stuart J. Connolly, Quilong Yi, Olga Shestakovska, Salim Yusuf, John W. Eikelboom

    Résumé Résumé Plan Plan   
  • ·Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry

    Page :69-76

    Yuichi Saito, Taku Inohara, Shun Kohsaka, Hideki Wada, Itaru Takamisawa, Kyohei Yamaji, Tetsuya Amano, Yoshio Kobayashi, Ken Kozuma, J-PCI Registry Investigators

    Résumé Résumé Plan Plan   
  • ·Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial

    Page :85-95

    Alexander C. Fanaroff, Samantha Coratti, Rim Halaby, Monika Sanghavi, Rupal P. O'Quinn, Sheela Krishnan, Helene Glassberg, Archna Bajaj, Srinath Adusumalli, Neel Chokshi, Mitesh S. Patel

    Résumé Résumé Plan Plan   
  • ·Public reporting of black participation in anti-hypertensive drug clinical trials

    Page :129-139

    Michael D. Green, Mahalia R. Dalmage, Jay B. Lusk, Emilie F. Kadhim, Lesley A. Skalla, Emily C. O'Brien

    Résumé Résumé Plan Plan   
  • ·Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities

    Page :140-148

    Eva Havers-Borgersen, Jawad H. Butt, Jarl Strange, Christian L. Carranza, Lars Køber, Emil L. Fosbøl

    Résumé Résumé Plan Plan   
  • ·Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

    Page :149-156

    Ankeet S. Bhatt, Lori B. Daniels, James de Lemos, Erica Goodrich, Erin A. Bohula, David A. Morrow, On behalf of the AHA COVID-19 CVD Registry Investigators

    Résumé Résumé Plan Plan   
  • ·Evaluation of the association between circulating IL-1β and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women

    Page :157-167

    Sofia E. Gomez, Justin Parizo, Simon Ermakov, Joseph Larson, Robert Wallace, Themistocles Assimes, Mark Hlatky, Marcia Stefanick, Marco V. Perez

    Résumé Résumé Plan Plan  
  • ·Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy

    Page :177-185

    Guangguo Fu, Zhuoming Zhou, Bohao Jian, Suiqing Huang, Zicong Feng, Mengya Liang, Quan Liu, Yang Huang, Kaizheng Liu, Guangxian Chen, Zhongkai Wu

    Résumé Résumé Plan Plan   

• Research Letters

  • ·Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic

    Page :114-118

    Fouad Chouairi, Bret Pinsker, Marat Fudim, P. Elliott Miller

    Résumé Résumé Plan Plan   

• Letter to the Editors

  • ·Some inquiries about the currently launched BROKEN SWEDEHEART therapeutic trial for takotsubo syndrome

    Page :190-191

    John E. Madias

    Plan Plan